Dr. Abbey Discusses Latest Dry AMD Treatment Research on New Podcast Episode
Texas Retina Associates Blog
by Debbie Muse
4h ago
While anti-VEGF injections are widely used to treat patients with wet age-related macular degeneration (AMD), there have been limited treatment options available for dry AMD other than AREDS vitamin formulations and lifestyle modifications. In the latest episode of “Blind Spot – The Eye Doctor’s Podcast,” Texas Retina’s Ashkan Abbey, MD, discusses the most recent research on new injectable medications available for some patients with dry AMD.  You can access the full podcast episode here. About Ashkan Abbey, MD Dr. Abbey serves as Texas Retina’s Director of Clinical Research for Dallas an ..read more
Visit website
Understanding Your Insurance Coverage in the New Year: How Prior Authorizations Can Impact Retina Care
Texas Retina Associates Blog
by Debbie Muse
4h ago
Health insurance policies and coverage vary greatly. As we start a new year, it is important to understand how your specific plan works and how that can affect your retina care. Referrals and Prior Authorizations for Retina Care Some health plans require a referral from your primary care physician to receive care from any specialist, including our physicians here at Texas Retina. Some plans also require that you choose a physician in their network. In addition, many insurance plans, especially Medicare Advantage plans, are increasingly requiring a prior authorization for certain procedures and ..read more
Visit website
Office Closures for 1/10/2025
Texas Retina Associates Blog
by Debbie Muse
6d ago
Due to the winter weather, the following Texas Retina offices are CLOSED today, January 10, 2025: Dallas North Athens Denton Grapevine Mansfield Sherman Wichita Falls If you have an appointment scheduled that is impacted by these closures, no need to call us. We will be reaching out to you to reschedule. The following Texas Retina offices are OPEN today – Dallas Main, Arlington, Fort Worth, Frisco, Lubbock, Plano, Rockwall and Waco. We ask that all callers be patient with us as we continue to experience a high volume of calls. Stay safe! The post Office Closures for 1/10/2025 first appeared on ..read more
Visit website
Winter Weather Closures
Texas Retina Associates Blog
by Debbie Muse
6d ago
Due to the winter weather, the following Texas Retina offices are CLOSED today, January 9, 2025: Dallas North Arlington Athens Frisco Denton Fort Worth Grapevine Plano Sherman Wichita Falls If you have an appointment scheduled that is impacted by these closures, no need to call us. We will be reaching out to you to reschedule. The following Texas Retina offices are OPEN today, January 9, 2025: Dallas Main, Rockwall, Waco, Mansfield and Lubbock. We ask that all callers be patient with us this morning as we are experiencing a high volume of calls. Stay safe! The post Winter Weather Closures firs ..read more
Visit website
Understanding Your Insurance Coverage in the New Year: How Prior Authorizations Can Impact Retina Care
Texas Retina Associates Blog
by Debbie Muse
6d ago
Health insurance policies and coverage vary greatly. As we start a new year, it is important to understand how your specific plan works and how that can affect your retina care. Referrals and Prior Authorizations for Retina Care Some health plans require a referral from your primary care physician to receive care from any specialist, including our physicians here at Texas Retina. Some plans also require that you choose a physician in their network. In addition, many insurance plans, especially Medicare Advantage plans, are increasingly requiring a prior authorization for certain procedures and ..read more
Visit website
Dr. Anand Participated in Research on New Gene Therapy Drug for X-linked Retinitis Pigmentosa Published in American Journal of Ophthalmology
Texas Retina Associates Blog
by Debbie Muse
6d ago
The two-year results of the Phase I/II, multi-center HORIZON clinical trial of the new subretinal gene therapy drug AGTC-501 for X-linked retinitis pigmentosa were recently published in the American Journal of Ophthalmology. Texas Retina’s Rajiv Anand, MD, serves as an investigator for this ongoing, five-year study evaluating the drug’s safety and efficacy, along with David Birch, PhD, Scientific Director at the Retina Foundation of the Southwest (Retina Foundation) in Dallas, and leaders at three other centers in the United States. Understanding X-linked Retinitis Pigmentosa The most common i ..read more
Visit website
2025 New Year’s Resolutions for Your Eyes
Texas Retina Associates Blog
by Debbie Muse
1w ago
As 2025 begins, it is the perfect time to commit to living a healthy lifestyle. Here are eight New Year’s resolutions to improve your eye health and protect your vision: 1. Schedule an annual, comprehensive eye exam. Regular eye exams by an ophthalmologist or optometrist are critical to maintaining the overall health of your eyes even if you aren’t experiencing any vision issues. Early detection of common eye diseases like diabetic retinopathy and macular degeneration is important to achieve optimal treatment. During an eye exam, your eye doctor may even spot early signs of other overall healt ..read more
Visit website
Happy New Year!
Texas Retina Associates Blog
by Debbie Muse
2w ago
Happy New Year! Our offices will be closed on Wednesday, January 1, 2025. As another year comes to a close, we want to thank all of our patients, referring physicians, neighbors and friends for placing your trust in our team. We wish you all the best for a happy, healthy 2025! The post Happy New Year! first appeared on Texas Retina Associates ..read more
Visit website
Holiday Office Closure
Texas Retina Associates Blog
by Debbie Muse
3w ago
Happy Holidays from Texas Retina! Our offices will be closed Tuesday, December 24, 2024, and Wednesday, December 25, 2024. We wish you and your family health and happiness this holiday season! The post Holiday Office Closure first appeared on Texas Retina Associates ..read more
Visit website
Dr. Abbey Reports on New Method to Measure Retinal Fluid After Treatment with Faricimab for Wet AMD
Texas Retina Associates Blog
by Debbie Muse
3w ago
Texas Retina’s Ashkan M. Abbey, MD, recently co-authored an article in the medical journal Eye on the use of a novel deep-learning algorithm to quantify retinal fluid changes in patients treated with faricimab for neovascular (wet) age-related macular degeneration (AMD) through the TRUCKEE study. Called the Notal OCT Analyzer (NOA) algorithm, this new measurement approach provided researchers with intraretinal, subretinal and total retinal fluid counts for each optical coherence tomography (OCT) scan conducted on the 521 eyes included in their review. Reducing Retinal Fluid Accumulation to Hel ..read more
Visit website

Follow Texas Retina Associates Blog on FeedSpot

Continue with Google
Continue with Apple
OR